key: cord-0682415-lis1t474 authors: Lucas, Kurt; Ackermann, Maximilian; Leifke, Anna Lena; Li, William W.; Pöschl, Ulrich; Fröhlich-Nowoisky, Janine title: Ceylon cinnamon and its major compound Cinnamaldehyde can limit overshooting inflammatory signaling and angiogenesis in vitro: implications for COVID-19 treatment date: 2021-06-16 journal: bioRxiv DOI: 10.1101/2021.06.16.448642 sha: 5f937c693a48bf388112e2f551a102789762c921 doc_id: 682415 cord_uid: lis1t474 Overshooting immune reactions can occur during inflammatory responses that accompany severe infections, such as COVID-19. Cytokines, damage-associated molecular patterns (DAMPs), and reactive oxygen and nitrogen species can generate positive feedback loops of inflammation, leading to long-term complications such as vascular endothelialitis, thrombosis, endothelial dysfunction, neurological impairments, and chronic fatigue. Dexamethasone can limit inflammation by inhibiting the activation of pro-inflammatory transcription factors. High dose dexamethasone, however, has undesirable side effects. Here, we show that Ceylon cinnamon and its major compound cinnamaldehyde can mitigate inflammatory signaling in vitro. Cinnamaldehyde interferes with the dimerization of toll-like receptor 4 (TLR4), which can be activated by DAMPs like HSP60 and HMGB1. Our results suggest that supplementary treatment with Ceylon cinnamon may allow administration of lower doses of dexamethasone to avoid high dose steroid side effects. Moreover, preliminary results indicate that Ceylon cinnamon modulates angiogenesis, which is a reactive phenomenon in COVID-19. Introduction 1), regulating the expression of hundreds of inflammatory genes, including the pro-67 inflammatory cytokines 12) , generating a positive feedback loop (Fig. 1) . 68 Moreover, damage-associated molecular patterns (DAMPs) like heat shock protein 60 69 (HSP60), high mobility group box 1 (HMGB1), and calprotectin (S100A8/A9 hetero tetramer) 70 can be released during immune reactions elicited by . These 71 DAMPs can activate pattern recognition receptors such as TLR2, TLR4, and RAGE (14, and generate additional positive feedback via NF-κB, as has been shown for TLR4 ( Pro-inflammatory cytokines cause activation of NF-κB, which amplifies their production, 81 resulting in a positive cytokine feedback loop. In addition, DAMPs can be released and 82 activate NF-κB via TLR4 and other pattern recognition receptors, generating a further 83 feedback loop. Moreover, interactions with ROS/RNS can form chemically modified DAMPs (mod-DAMPs) with enhanced TLR4-stimulating potential, additionally fueling inflammation. 85 Dexamethasone inhibits activation of NF-κB, whereas cinnamaldehyde, the major active 86 compound of ethanolic Ceylon cinnamon extract, inhibits activation of TLR4, thus disrupting 87 the feedback loops. 88 89 One of the clinical goals for the treatment of COVID-19 is to mitigate an excessive 90 inflammatory response to SARS-CoV-2 infection. Dexamethasone, a corticosteroid which 91 acts on 23) is an effective therapeutic intervention for moderate to severe 92 disease (4, 24), but it can cause unwanted side effects in high doses. TLR4 could be another 93 potential target for treatment of COVID-19 since it plays an important role in the DAMP-94 driven positive feedback loops (Fig. 1) . Cinnamaldehyde (CA), the major active compound of 95 Ceylon cinnamon (Cinnamomum verum) extract (CCE) (25-27) can inhibit the activation of 96 TLR4 by preventing receptor dimerization (28). As shown in an animal model, the concurrent 97 intake of Cinnamon can also mitigate the side effects of dexamethasone (29). We 98 hypothesized that Ceylon cinnamon or cinnamaldehyde might be well suited as a 99 supplementary treatment for COVID-19 to lower the risk of the 'cytokine storm' and allow 100 administration of reduced dosages of dexamethasone to mitigate steroid-induced side-101 effects (30). 102 In this study, we compared CCE and CA with dexamethasone in the suppression of TLR4-103 dependent cytokine mRNA production and IL-8 protein release in vitro. Further, we present 104 preliminary data showing that CCE inhibits tube formation, which serves as a cellular model 105 for angiogenesis. 106 We do not recommend the use of Cassia cinnamon or its extracts, due to its possibly high 107 content of liver-toxic coumarin (31). 108 Ceylon cinnamon extract (CCE) was prepared by extraction from Ceylon cinnamon powder 111 (Cinnamomi ceylanici cortex, Caesar & Loretz GmbH, Hilden, Germany) with 70% ethanol 112 (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) in a 1:5 ratio and incubation for 10 113 days at room temperature, protected from light and shaken once daily. After the incubation 114 period, the CCE was filtered through a 0.22-µM pore size PES membrane filter unit (Corning 115 Inc., Corning, USA) under sterile conditions and stored in brown glass bottles at room 116 temperature protected from light. In a previous study, a CCE concentration of 0.3% was 117 determined to be optimal for the treatment of THP-1 cells (26) For qPCR analysis, cells were seeded in 6-well cell culture plates at a density of 4x10 5 153 cells/mL and treated in triplicate with 0.3% cinnamon extract, 3.2 µM or 6.2 µM 154 dexamethasone, and CA in a range of 20 µM-50 µM plus vehicle control as described 155 above. LPS incubation was carried out for 1 h and 4 h. After incubation, cells were separated 156 from supernatants by centrifugation (500 x g, 5 min), lysed in RLT buffer (RNeasy Mini Kit; 157 Qiagen, Hilden, Germany) and stored at -80 °C for RNA extraction and real-time quantitative 158 PCR. Two independent experiments were performed on different days. 159 Interleukin-8 secretion of treated THP-1 monocytes was quantified by the ELISA OptEIA™ 161 Set for human interleukin-8 (BD) following the manufacturer's protocol with optimized wash 162 buffer composition (50x dilution). The cell supernatants were diluted in a range of 1:2-1:20 163 and tested in triplicate. The absorbance wavelength of 450 nm and reference wavelength of 164 570 nm were determined on a Synergy NEO plate reader. Using Gen5 software (Biotek), the 165 reference wavelength values were subtracted from the absorbance wavelength values. 166 Based on measured standard values, a standard curve was constructed. IL-8 cytokine 167 production was calculated according to the standard curve and respective dilution factors. 168 Statistical analysis and corresponding graphs were generated with Prism 9 software 169 (GraphPad Software, San Diego, USA). 170 Real-time quantitative PCR (qPCR) was performed to quantify mRNA expression of IL1-β, 172 IL-8, and TNF. Extraction of total RNA from cells was performed using the RNeasy Mini Kit 173 (Qiagen) according to the manufacturer's protocol. Purified RNA was eluted with 30 µL 174 RNase-free water. Total RNA yield was determined by measuring absorbance at 260 nm, 175 280 nm, and 320 nm using Take3 Trio Micro-Volume Plates (Biotek) in combination with the 176 Synergy NEO plate reader. All samples were adjusted to an RNA concentration of 50 ng/µL. 177 Single-strand cDNA was synthesized from 500 ng RNA per sample using the High-Capacity 178 cDNA Reverse Transcription Kit (Thermo Fisher Scientific) following the standard protocol. were designed with Primer-BLAST software (NCBI) ( Table 1) . Peptidylprolyl Isomerase A (PPIA) and TATA-Box Binding Protein (TBP) served as reference genes (33). The following 184 thermal cycling protocol was used: 98 °C for 30 s followed by 40 cycles of 98 °C for 10 s, 185 and 60 °C for 25 s. Data analysis was performed with CFX Manager software 3.1 (Bio-Rad) 186 using the 2− ΔΔCT method to calculate gene expression. For qPCR, all samples were tested in 187 technical duplicates and arithmetic mean and standard deviation values were calculated. 188 Prism 9 software (GraphPad Software) was used for statistical analysis. Eindhoven; Netherlands). 211 To evaluate toxicity, an alamarBlue TM assay was performed to determine cell viability (Fig. 226 2). Ceylon cinnamon extracts at concentrations of 0.2% and 0.3% elicited no toxic effects in 227 THP-1 cells, which is in accordance with previous results (26) We next tested the efficacy of CCE and CA in inhibiting IL-1β, IL-8, and TNF mRNA 234 expression and IL-8 protein release in THP-1 monocytes (Fig. 3, Fig. 4) . In previous studies, 235 we determined that a concentration of 0.3% CCE is most effective in THP-1 cells (26, 27) . The mRNA expression of all tested NF-κB-regulated cytokines was strongly enhanced 1 h 252 after stimulation with 50 ng/mL LPS with sharp decreases in the induction by 4 h (Fig. 3) . 253 The used ethanol concentrations had no impact on gene expression. Treatment with 0.3% 254 CCE drastically inhibited the LPS-stimulated increases in the mRNA expression of all three 255 cytokines. In contrast, the inhibitory effects of 3.2 µM and 6.4 µM dexamethasone after 1 h 256 were relatively lower, but similar to CCE after 4 h. This suggests that the effects of 257 dexamethasone on inflammatory signaling pathways are not immediate (36). 258 Cinnamaldehyde showed a clear dose dependence in reducing the mRNA expression of all 259 three cytokines examined (Fig. 3) . This was expected, since the cinnamaldehyde in CCE 260 interferes with TLR4 receptor dimerization and thus inhibits the activation of NF-κB by LPS 261 (28). This can explain the faster action of cinnamaldehyde compared to dexamethasone, 262 because inflammatory TLR4 signaling is blocked already outside the cell. As shown in Figure 263 2, a CA concentration of 50 µM elicited cytotoxic effects, which additionally influences gene 264 expression. Concentrations of 30 µM CA and 3.2 µM dexamethasone were similarly potent 265 in suppressing inflammatory signaling. In these experiments, the effect of 30 µM CA on IL-1β 266 and TNF expression was comparable to that of CCE, but the effect was less pronounced for 267 IL-8. Overall, whole CCE seems to be more efficient than cinnamaldehyde in the 268 suppression of mRNA expression of inflammatory genes. We also observed this 269 phenomenon in a previous study; one possible explanation might lie in the synergistic effects THP-1 monocytes were pre-incubated with 0.2% or 0.3% CCE, equivalent concentrations of 282 ethanol, or with 3.2 µM or 6.4 µM dexamethasone (Fig. 4A) , and seven different 283 concentrations of CA (Fig. 4B) . LPS was added in a final concentration of 50 ng/mL, and the 284 cells were incubated for a further 4 h. Supernatants were collected and analyzed by IL-8 285 ELISA. The baseline IL-8 expression of untreated cells was set to zero, while the IL-8 286 expression of the LPS-treated cells was set to 100% in both experimental settings. The 287 addition of 0.2% and 0.3% ethanol had no effect on IL-8 protein expression. CCE in a 288 concentration of 0.2% had a similar effect to 3.2 µM or 6.4 µM dexamethasone (Fig 4A) . 289 CCE at a concentration of 0.3% was more effective for the suppression of IL-8 than either of 290 the dexamethasone concentrations used. CA at concentrations of 30 µM and 40 µM 291 inhibited TLR4-dependent IL-8 expression to an extent comparable to the dexamethasone 292 concentrations used (Fig. 4B) . 293 294 Taken together, CCE and CA can dampen the activation of TLR4-dependent pathways 295 during inflammation. This suggests that cinnamon compounds may also reduce the 296 ROS/RNS-stimulated, DAMP-mediated activation of TLR4 during severe inflammation 297 (Fig. 1) . 298 299 Reactive angiogenesis is another complication present in SARS-CoV-2-infected organs in 301 COVID-19. The tube formation assay in HUVEC cells is a common cellular model for 302 angiogenesis (37). We carried out preliminary tube formation assay experiments in vitro to 303 determine whether CCE can also mitigate this complication of COVID-19. 304 membrane extract matrix, they start to form a tube-like network (Fig. 5A ). This 319 morphogenetic pattern is caused by a sprouting of endothelial cells, which is routinely used 320 as a surrogate for angiogenesis. The temporal analysis of this morphogenetic process by 321 fluorescence light microscopy revealed an inhibitory effect of 0.1% CCE after 3.5 h and 6 h 322 hours (Fig. 5B) , whereas higher dosages (0.5% and 1.0% cinnamon, Fig. 5C and 5D ) 323 showed direct cytotoxic effects. The analysis of this sprouting process by scanning electron 324 microscopy (SEM) showed an altered cell morphology in response to 0.1% CCE (Fig. 5F) . 325 Higher dosages resulted in cellular damage and apoptosis ( Fig. 5G and 5H) . 326 The inhibition of angiogenesis by CCE and CA is well documented in the literature (38) (39) (40) (41) (42) (43) . 327 Suprisigly one studie find a angigenesis promoting effect for CA in the context of 328 wouldhealing (44). 329 Despite the clinical efficacy of dexamethasone for COVID-19 patients, unwanted side-effects 331 are known for corticosteroids, e.g. steroid psychosis (45) cinnamon vary between 500 mg and 3 g per day for adults (50-54). However, to the best of 347 our knowledge, no study administering cinnamon alone or in combination with 348 dexamethasone for COVID-19 has been published to date. Therefore, clinical studies are 349 needed before the treatment of COVID-19 patients with cinnamon or its compounds can be 350 recommended. The Ceylon cinnamon should be of pharmaceutical grade as described here. 351 Since dexamethasone and cinnamon act to dampen inflammation via distinct pathways, we 352 suggest that these compounds are likely to have synergistic effects when administered 353 concomitantly. 354 Cinnamon has been used as a medicine for thousands of years in traditional medical 356 practices (55). Its anti-inflammatory effects are well documented. The inhibition of TLR4 357 dimerization, in particular, is an important anti-inflammatory mechanism (28). During the so 358 called 'cytokine storm', not only cytokines but also ROS/RNS and DAMPs contribute to 359 amplification of inflammation (56). Our results indicate that dexamethasone, which is now 360 being used to dampen excessive inflammation in COVID-19, could be combined with a 361 Ceylon cinnamon preparation. In contrast to dexamethasone, which inhibits the activity of 362 the pro-inflammatory transcription factor NF-κB (22), cinnamon can suppress the secondary 363 activation of TLR4 by DAMPs (28). These differences in modes of action suggest the 364 possibility of synergistic effects. Further studies may pave the way towards clinical studies of 365 cinnamon derivatives for the treatment of Our results suggest that intake of Ceylon cinnamon in combination with dexamethasone may 367 prevent the 'cytokine storm' and help to reduce the dosage of dexamethasone and mitigate 368 its side effects. Preliminary results indicate that cinnamon may also reduce angiogenesis. 369 Note, however, that Ceylon cinnamon should not be substituted by Cassia cinnamon, which 370 may comprise high amounts of liver-toxic coumarin (31). Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. The New England journal of 381 medicine Immediate and long-term 383 consequences of COVID-19 infections for the development of neurological disease COVID-19 cardiac injury: Implications for long-term 386 surveillance and outcomes in survivors Severe Covid-19. The New England journal of medicine Molecular hydrogen (H(2) ) as a potential treatment for acute 390 and chronic fatigue The cytokine storm and COVID-19 The pathogenesis and treatment of the `Cytokine Storm Early IL-1 receptor 395 blockade in severe inflammatory respiratory failure complicating COVID-19. Proceedings of the 396 National Academy of Sciences of the United States of America Profiling serum cytokines in COVID-19 398 patients reveals IL-6 and IL-10 are disease severity predictors. Emerging microbes & infections Sex differences in 401 immune responses that underlie COVID-19 disease outcomes NF-κB signaling in inflammation. Signal Transduction and 403 Targeted Therapy IL-8 and p53 405 are inversely regulated through JNK, p38 and NF-κB p65 in HepG2 cells during an inflammatory 406 response Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine 409 release. The Journal of experimental medicine COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse 411 outcome? American journal of physiology Heart and circulatory physiology Extracellular HMGB1: a therapeutic target in severe 413 pulmonary inflammation including COVID-19? Molecular medicine HMGB1 as a potential biomarker and 418 therapeutic target for severe COVID-19 Elevated serum levels of S100A8/A9 and 420 HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients Chemical 423 modification of pro-inflammatory proteins by peroxynitrite increases activation of TLR4 and NF-κB: 424 Implications for the health effects of air pollution and oxidative stress Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: 428 possible treatments targeting the TLR4 pathway Mechanistic insights into corticosteroids in 430 multiple sclerosis: war horse or chameleon? The glucocorticoid 432 receptor recruits the COMPASS complex to regulate inflammatory transcription at macrophage 433 enhancers Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute 436 Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial The Toll-Like Receptor Radical Cycle Pathway: A 439 New Drug Target in Immune-Related Chronic Fatigue. CNS & neurological disorders drug targets Screening of 442 herbal extracts for TLR2-and TLR4-dependent anti-inflammatory effects Anti-445 inflammatory effects of cinnamon extract and identification of active compounds influencing the 446 TLR2 and TLR4 signaling pathways Cinnamaldehyde suppresses 448 toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. 449 Biochemical pharmacology Cinnamomum Zeylanicum Bark against Glucocorticoid Induced Atherosclerosis in Wistar Rats Cinnamon and hop extracts as 454 potential immunomodulators for severe COVID-19 cases. Front Plant Sci Cassia cinnamon as a source of 456 coumarin in cinnamon-flavored food and food supplements in the United States Effects of anti-459 inflammatory compounds on sulfur mustard injured cells: Recommendations and caveats suggested 460 by in vitro cell culture models Gene expression results in lipopolysaccharide-462 stimulated monocytes depend significantly on the choice of reference genes Endothelial cell tube formation assay for the in vitro study of angiogenesis Dexamethasone modulates binding and 470 action of epidermal growth factor in serum-free cell culture. Proceedings of the National Academy of 471 Sciences of the United States of America Evaluation of Angiogenesis Assays Novel angiogenesis inhibitory activity in 475 cinnamon extract blocks VEGFR2 kinase and downstream signaling Cinnamon extract inhibits 478 angiogenesis in zebrafish and human endothelial cells by suppressing VEGFR1, VEGFR2, and PKC-479 mediated MAP kinase. Food science & nutrition Cinnamic aldehyde suppresses hypoxia-induced 481 angiogenesis via inhibition of hypoxia-inducible factor-1α expression during tumor progression. 482 Biochemical pharmacology Cinnamon from the selection of 484 traditional applications to its novel effects on the inhibition of angiogenesis in cancer cells and 485 prevention of Alzheimer's disease, and a series of functions such as antioxidant, anticholesterol, 486 antidiabetes, antibacterial, antifungal, nematicidal, acaracidal, and repellent activities Cinnamon extract reduces 489 VEGF expression via suppressing HIF-1α gene expression and inhibits tumor growth in mice. 490 Molecular carcinogenesis The inhibition of hypoxia-induced 492 angiogenesis and metastasis by cinnamaldehyde is mediated by decreasing HIF-1α protein synthesis 493 via PI3K/Akt pathway Cinnamaldehyde accelerates wound 495 healing by promoting angiogenesis via up-regulation of PI3K and MAPK signaling pathways. 496 Laboratory investigation; a journal of technical methods and pathology Side effects of corticosteroid injections: what's new? 498 Joint bone spine Adverse side effects of dexamethasone in surgical patients The effect of corticosteroids on mortality of 503 patients with influenza pneumonia: a systematic review and meta-analysis Improved Insulin Resistance and Lipid 506 Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated 507 Receptors Cinnamon extract regulates glucose transporter and insulin-509 signaling gene expression in mouse adipocytes. Phytomedicine : international journal of 510 phytotherapy and phytopharmacology Cinnamon improves glucose and 512 lipids of people with type 2 diabetes Efficacy of cinnamon in 514 patients with type II diabetes mellitus: A randomized controlled clinical trial Effect of cinnamon 517 on migraine attacks and inflammatory markers: A randomized double-blind placebo-controlled trial